Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...

Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Na ...

Inside the Movement to Destroy American Democracy” lifts the curtain on Donald Trump’s authoritarian movement.

The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...

Q4 2024 Earnings Call Transcript February 5, 2025 CSG Systems International, Inc. beats earnings expectations. Reported EPS ...

If you think about it, most of these products are cheaper than checking a bag — I hope that's all the justification you need.

Those of our readers who pay close attention to our masthead on the front page may have noted that The Chronicle hit a significant milestone this year.

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...